Page 136 - TD-4-1
P. 136

Tumor Discovery                                                    An ominous and rare variant of melanoma



            such as the use of sunscreen and protective clothing,   Dermatol. 2014;89(4):666-668.
            remain critical in reducing ultraviolet radiation-induced      doi: 10.1590/abd1806-4841.20142802
            DNA damage.
                                                               4.   Pedersen EA, Harms PW, Zhao L, et al. Polypoid melanoma
            Acknowledgments                                       is associated with aggressive histopathological characteristics
                                                                  and poor clinical prognosis: A retrospective cohort study.
            None                                                  J Am Acad Dermatol. 2023;88(5):1169-1170.

            Funding                                               doi: 10.1016/j.jaad.2022.11.055
                                                               5.   Maury  ME,  Jukic  DM.  A  case  presentation  of  three
            None.
                                                                  polypoid melanomas with divergent features.  Cureus.
            Conflict of interest                                  2023;15(10):e46951.
                                                                  doi: 10.7759/cureus.46951
            The authors declare that they have no competing interests.
                                                               6.   Navarro-Nuño   DE,    Villarreal-Salgado   JL,
            Author contributions                                  Grano-González VH, García-Marín G, Nuño-Rodríguez VH,
                                                                  Torres-Salazar QL. Surgical technique for margin widening
            Conceptualization: Emmanuel Zappettini                in the treatment of polypoid nodular malignant back
            Investigation: Emmanuel Zappettini                    melanoma. Int J Surg Case Rep. 2023;110:108659.
            Writing-original draft: Sergio Fernández Vértiz       doi: 10.1016/j.ijscr.2023.108659
            Writing-review & editing: Sergio Fernández Vértiz
                                                               7.   Kalmykova  A,  Mosaieby  E,  Kacerovská  D,  et al.
            Ethics approval and consent to participate            MITF::CREM-rearranged tumor: a novel group of cutaneous
                                                                  tumors with melanocytic differentiation.  Virchows Arch.
            The study was approved by the Ethical Committee of our   2023;483(4):569-575.
            institution. The authors certify that appropriate consent      doi: 10.1007/s00428-023-03621-7
            was  obtained  from  the  patient.  The  patient gave  his
            consent and understands that his name and initials will   8.   Tan  A,  Gutierrez  D,  Brinster  NK,  Stein  JA.  Polypoid
            not be published. Efforts are made to conceal his identity,   melanoma mistaken for verruca vulgaris. Cleve Clin J Med.
            although anonymity cannot be guaranteed.              2020;87(9):534-536.
                                                                  doi: 10.3949/ccjm.87a.19079
            Consent for publication
                                                               9.   Boccardi A, Trigg J, Reite, P, Papadopoulos D, Sirota
            The patient gave his consent for his images and other   Rozenberg  S.  Polypoid  melanoma:  Diagnostic  hardships
            clinical information to be reported in the manuscript.  concerning a rare melanoma variant.  SKIN J Cutan Med.
                                                                  2022;6(3):250-253.
            Availability of data                                  doi: 10.25251/skin.6.3.13
            Data used in this work are available from the corresponding   10.  Schadendorf D, Luke JJ, Ascierto PA, et al. Pembrolizumab
            author upon reasonable request.                       versus placebo as adjuvant therapy in resected stage IIB or
                                                                  IIC  melanoma:  Outcomes  in  histopathologic  subgroups
            References                                            from the randomized, double-blind, phase 3 KEYNOTE-716
            1.   Valdebran M, Wu K, Wu A, Junkins-Hopkins J. Polypoid   trial. J Immunother Cancer. 2024;12(3):e007501.
               melanoma: A rare clinical subtype frequently confused with      doi: 10.1136/jitc-2023-007501
               benign entities. Our Dermatol Online. 2016;7(2):179-180.
                                                               11.  Michielin  O,  van  Akkooi  ACJ,  Ascierto  PA,  Dummer  R,
            2.   Di Altobrando A, Patrizi A, Dika E, Savoia F. Cauliflower-  Keilholz U; ESMO Guidelines Committee. Electronic address:
               like  exophytic  mass  on  the  skin:  Polypoid  melanoma.   clinicalguidelines@esmo.org. Cutaneous melanoma: ESMO
               Clinical, dermoscopic, and histologic features.  An Bras   Clinical  Practice  Guidelines  for  diagnosis,  treatment  and
               Dermatol. 2020;95(6):748-750.                      follow-up. Ann Oncol. 2019;30(12):1884-1901.
               doi: 10.1016/j.abd.2020.04.010                     doi: 10.1093/annonc/mdz411
            3.   Hikawa RS, Kanehisa ES, Enokihara MM, Enokihara MY,   12.  Pérez-Wilson J, Arellano J, Castro A. Polypoid melanoma:
               Hirata SH. Polypoid melanoma and superficial spreading   an aggressive variant of nodular melanoma.  Cutis.
               melanoma different subtypes in the same lesion.  An Bras   2018;101(6):E6-E7.







            Volume 4 Issue 1 (2025)                        128                                doi: 10.36922/td.5105
   131   132   133   134   135   136   137   138   139   140   141